AAAAAA

   
Results: << | 101-104 |
Results: 101-104/104

Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HEINZE B GEORGII A VONWUSSOW P BARTRAM C GRIESSHAMMER M BERGMANN L ESSERS U FALGE C HOCHHAUS A QUEISSER U SICK C MEYER P SCHMITZ N VERPOORT K EIMERMACHER H WALTHER F WESTERHAUSEN M KLEEBERG UR HEILEIN A KABISCH A BARZ C ZIMMERMANN R MEURET G TICHELLI A BERDEL WE KANZ L ANGER B TIGGES FJ SCHMID L BROCKHAUS W ZANKOVICH R SCHLAFER U WEISSENFELS I MAINZER K TOBLER A PERKER M HOHNLOSER J MESSENER D THIELE J BUHR T ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA, Blood, 82(2), 1993, pp. 398-407

Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ HOSSFELD DK HEINZE B HOCHHAUS A PRALLE H QUEISSER W LOFFLER H ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS BUSULFAN - PROLONGATION OF SURVIVAL BY INTERFERON-ALPHA IN CHRONIC PHASE CML, Blood, 82(10), 1993, pp. 10000330-10000330

Authors: SCHREZENMEIER H SPATHSCHWALBE E DRECHSLER S FARBER L STROMEYER P PORZSOLT F HEIMPEL H RAGHAVACHAR A
Citation: H. Schrezenmeier et al., PHASE-I TRIALS OF INTERLEUKIN-6 (IL-6) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC) AND PATIENTS WITH APLASTIC-ANEMIA (AA) - EFFECTS OF LONG-TERM APPLICATION AND DIFFERENCES OF HEMATOPOIETIC RESPONSE TO IL-6 IN PATIENTS WITH NORMAL HEMATOPOIESIS VERSUS PATIENTS WITH APLASTIC-ANEMIA, Blood, 82(10), 1993, pp. 10000368-10000368

Authors: VONWUSSOW P HEHLMANN R NOLTE KU JAKSCHIES D HOCHHAUS T WITTE T ANSARI H HASFORD J PRUMMER O HEIMPEL H DEICHER H
Citation: P. Vonwussow et al., RIFN-ALPHA-2A (ROFERON) IS MORE IMMUNOGENIC THAN RIFN-ALPHA-2B (INTRON-A) IN PATIENTS WITH CML, Blood, 82(10), 1993, pp. 10000378-10000378
Risultati: << | 101-104 |